Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Case Study of Pfizer and Astrazeneca, Focusing on Methods of Increasing Sales Force Productivity.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c30316) has announced the addition of Pfizer Pfizer Incorporated (NYSE: PFE) is a major research-based pharmaceutical company, which ranks number two in sales The company is based in New York City. It produces the number-one selling drug Lipitor (atorvastatin, used to lower blood cholesterol); the oral antifungal  And Astrazeneca Case Studies: Enhancing Sales Team Tactics to their offering.

This report focuses on two methods of enhancing sales force productivity within the pharmaceutical industry, namely increasing sales force numbers and improving sales force training.

Topics Covered

WHAT IS THIS REPORT ABOUT?

INTRODUCTION

CASE STUDY

Pfizer

Face-to-face detailing

Sales tactics

Lipitor Lip·i·tor

A trademark for the drug atorvastatin calcium.


atorvastatin calcium

Lipitor

Pharmacologic class: HMG-CoA reductase inhibitor

Therapeutic class:
 

The benefits of a desirable sales force

AstraZeneca

Virtual perceptorship training

How virtual preceptorship pre·cep·tor·ship
n.
A period of practical experience and training for a student, especially of medicine or nursing, that is supervised by an expert or specialist in a particular field.
 works

CONCLUSIONS

RESEARCH METHODOLOGY

RELATED RESEARCH

LIST OF FIGURES

Figure 1: Impact of US detailing spend on US sales, 2003

Figure 2: Pfizers Lipitor

Figure 3: AstraZeneca logo

For more information visit http://www.researchandmarkets.com/reports/c30316
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 9, 2006
Words:121
Previous Article:National Guard Presents WrestleMania(R) 22 Fan Axxess Tour Starting In January 2006.
Next Article:An Analysis of the Automotive Industry, Including the Worlds Leading Vehicle Manufacturers.
Topics:



Related Articles
WHEN BIG PHARMA CHASES MEGA PHARMA.
HIRC Research Finds Pfizer #1 for Programs; Novo Nordisk #1 for Pricing Flexibility.
Research and Markets: Astrazeneca, Glaxosmithkline (GSK), Pfizer, and Sanofi-Aventis the Four Pharmaceutical 'Mega Corporations' Have All Emerged...
New Research Examines How Successful the Pipeline Enhancement Process has been in Practice for four 'Mega Corporations' - AstraZeneca,...
Targeting High-Prescribing Physicians, Pfizer Inc. Ranked Best in Managed Care Pull-Through Programs, Cognet-X Inc. Reports.
ADVISORY/TargetRx CEO Mike Luby to Keynote at WBR's PharmaForce Conference; Pharma Sales and Marketing Expert to Discuss Sales Force Quality Metrics...
The Future of the Pharmaceutical Industry: Big Change Expected for Next Years.
View Leading Players in the Global Anticoagulants Market.
Research & Markets: Pfizer - With 35 Protein Projects in R&D, was on Course to Generate $1.5 billion in Protein Therapeutics in 2006.
Examine the Key Factors Driving Relaunch Decisions for Pharmaceutical Products.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles